BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andreou C, Pal S, Rotter L, Yang J, Kircher MF. Molecular Imaging in Nanotechnology and Theranostics. Mol Imaging Biol 2017;19:363-72. [PMID: 28349293 DOI: 10.1007/s11307-017-1056-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Siddique S, Chow JCL. Recent Advances in Functionalized Nanoparticles in Cancer Theranostics. Nanomaterials 2022;12:2826. [DOI: 10.3390/nano12162826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Cen P, Zhou Y, Cui C, Wei Y, Cheng Z, Wu S, Zhang H, Tian M. Optical molecular imaging and theranostics in neurological diseases based on aggregation-induced emission luminogens. Eur J Nucl Med Mol Imaging 2022. [PMID: 35781601 DOI: 10.1007/s00259-022-05894-7] [Reference Citation Analysis]
3 Woźniak-budych M, Maciejewska BM, Jurga S, Wieszczycka K. Atomic force microscopy as multifunctional microbial imaging and characterization platform. Handbook of Microbial Nanotechnology 2022. [DOI: 10.1016/b978-0-12-823426-6.00003-6] [Reference Citation Analysis]
4 Andreou C, Gregoriou Y, Ali A, Pal S. In vivo imaging with SERS nanoprobes. SERS for Point-Of-care and Clinical Applications 2022. [DOI: 10.1016/b978-0-12-820548-8.00003-5] [Reference Citation Analysis]
5 Aminolroayaei F, Shahbazi-Gahrouei D, Shahbazi-Gahrouei S, Rasouli N. Recent nanotheranostics applications for cancer therapy and diagnosis: A review. IET Nanobiotechnol 2021;15:247-56. [PMID: 34694670 DOI: 10.1049/nbt2.12021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Persano F, Gigli G, Leporatti S. HALLOYSITE-BASED NANOSYSTEMS FOR BIOMEDICAL APPLICATIONS. Clays Clay Miner . [DOI: 10.1007/s42860-021-00135-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Xuan S, de Barros AODS, Nunes RC, Ricci-Junior E, da Silva AX, Sahid M, Alencar LMR, Dos Santos CC, Morandi V, Alexis F, Iram SH, Santos-Oliveira R. Radioactive gold nanocluster (198-AuNCs) showed inhibitory effects on cancer cells lines. Artif Cells Nanomed Biotechnol 2020;48:1214-21. [PMID: 32940067 DOI: 10.1080/21691401.2020.1821698] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
8 Xue Y, Gao Y, Meng F, Luo L. Recent progress of nanotechnology-based theranostic systems in cancer treatments. Cancer Biol Med 2021:j. [PMID: 33861527 DOI: 10.20892/j.issn.2095-3941.2020.0510] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Zhou X, He C, Liu M, Chen Q, Zhang L, Xu X, Xu H, Qian Y, Yu F, Wu Y, Han Y, Xiao B, Tang J, Hu H. Self-assembly of hyaluronic acid-mediated tumor-targeting theranostic nanoparticles. Biomater Sci 2021;9:2221-9. [PMID: 33507179 DOI: 10.1039/d0bm01855d] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Alsaab HO, Al-Hibs AS, Alzhrani R, Alrabighi KK, Alqathama A, Alwithenani A, Almalki AH, Althobaiti YS. Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine. Int J Mol Sci 2021;22:1631. [PMID: 33562829 DOI: 10.3390/ijms22041631] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
11 Niendorf T, Beenakker JM, Langner S, Erb-Eigner K, Bach Cuadra M, Beller E, Millward JM, Niendorf TM, Stachs O. Ophthalmic Magnetic Resonance Imaging: Where Are We (Heading To)? Curr Eye Res 2021;46:1251-70. [PMID: 33535828 DOI: 10.1080/02713683.2021.1874021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
12 Kong Y, Zhang C, Liu K, Wagle Shukla A, Sun B, Guan Y. Imaging of dopamine transporters in Parkinson disease: a meta-analysis of 18 F/123 I-FP-CIT studies. Ann Clin Transl Neurol 2020;7:1524-34. [PMID: 32794655 DOI: 10.1002/acn3.51122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Onaciu A, Jurj A, Moldovan C, Berindan-neagoe I. Theranostic Nanoparticles and Their Spectrum in Cancer. Engineered Nanomaterials - Health and Safety 2020. [DOI: 10.5772/intechopen.88097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Indoria S, Singh V, Hsieh MF. Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review. Int J Pharm 2020;582:119314. [PMID: 32283197 DOI: 10.1016/j.ijpharm.2020.119314] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 26.5] [Reference Citation Analysis]
15 Sun P, Zhang Y, Li K, Wang C, Zeng F, Zhu J, Wu Y, Tao X. Image-guided surgery of head and neck carcinoma in rabbit models by intra-operatively defining tumour-infiltrated margins and metastatic lymph nodes. EBioMedicine 2019;50:93-102. [PMID: 31734170 DOI: 10.1016/j.ebiom.2019.10.055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
16 Amin K, Moscalu R, Imere A, Murphy R, Barr S, Tan Y, Wong R, Sorooshian P, Zhang F, Stone J, Fildes J, Reid A, Wong J. The future application of nanomedicine and biomimicry in plastic and reconstructive surgery. Nanomedicine 2019;14:2679-96. [DOI: 10.2217/nnm-2019-0119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Andreou C, Oseledchyk A, Nicolson F, Berisha N, Pal S, Kircher MF. Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting. J Vis Exp 2019. [PMID: 30958459 DOI: 10.3791/58389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
18 Seca C, Ferraresi A, Phadngam S, Vidoni C, Isidoro C. Autophagy-dependent toxicity of amino-functionalized nanoparticles in ovarian cancer cells. J Mater Chem B 2019;7:5376-91. [DOI: 10.1039/c9tb00935c] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
19 Du Y, Zaidi H. Single-Photon Emission Computed Tomography: Principles and Applications. Encyclopedia of Biomedical Engineering 2019. [DOI: 10.1016/b978-0-12-801238-3.10891-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Roberts S, Andreou C, Choi C, Donabedian P, Jayaraman M, Pratt EC, Tang J, Pérez-Medina C, Jason de la Cruz M, Mulder WJM, Grimm J, Kircher M, Reiner T. Sonophore-enhanced nanoemulsions for optoacoustic imaging of cancer. Chem Sci 2018;9:5646-57. [PMID: 30061998 DOI: 10.1039/c8sc01706a] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
21 Hricak H. 2016 New Horizons Lecture: Beyond Imaging—Radiology of Tomorrow. Radiology 2018;286:764-75. [DOI: 10.1148/radiol.2017171503] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
22 Zanganeh S, Spitler R, Hutter G, Ho JQ, Pauliah M, Mahmoudi M. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy. Immunotherapy 2017;9:819-35. [DOI: 10.2217/imt-2017-0041] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 6.6] [Reference Citation Analysis]
23 Wall MA, Shaffer TM, Harmsen S, Tschaharganeh DF, Huang CH, Lowe SW, Drain CM, Kircher MF. Chelator-Free Radiolabeling of SERRS Nanoparticles for Whole-Body PET and Intraoperative Raman Imaging. Theranostics 2017;7:3068-77. [PMID: 28839464 DOI: 10.7150/thno.18019] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
24 Elgqvist J. Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer. Int J Mol Sci 2017;18:E1102. [PMID: 28531102 DOI: 10.3390/ijms18051102] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 9.4] [Reference Citation Analysis]